Patent · US Active

Cytotoxic T cell response modifiers

US11802285B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

Philipp Beckhove · Heidelberg, DE
Michael Boutros · Heidelberg, DE
Nisit Khandelwal · Heidelberg, DE
Marco Breinig · Bad Rappenau, DE

Key dates

Filing date	Sep 6, 2019
Grant date	Oct 31, 2023
Priority date	—
Expiry date	May 9, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/705
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a compound selectively binding to a sensory receptor or selectively altering the expression of a sensory receptor for use in a method for treating or preventing a disease associated with a pathologic cellular cytotoxic T cell (CTL) response. Further, the invention relates to means for detecting a sensory receptor for use in a method for diagnosing cellular resistance against CTL response in a patient. The invention further embraces a method for determining the resistance of a cell against a CTL response in vitro and to a method for identifying agents that influence the response of cells to CTLs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.